zolbetuximab
astellas
[]
frontline zolbetuximab/mfolfox6 prolongs survival in cldn18.2+ advanced gastric/gej adenocarcinoma via #gi23
Co-founder @MassiveBio | Director of Oncology Research @capitalhealthnj | Entrepreneur | #genomics #Tech #AI #trials #cancer #GPT #unicorn #A17a -My Opinion